- Home
- DNTH vs CCBG Comparison
DNTH vs CCBG Comparison
Compare DNTH & CCBG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNTH
- CCBG
- Stock Information
- Founded
- DNTH 2015
- CCBG 1895
- Country
- DNTH United States
- CCBG United States
- Employees
- DNTH N/A
- CCBG N/A
- Industry
- DNTH Biotechnology: Pharmaceutical Preparations
- CCBG Major Banks
- Sector
- DNTH Health Care
- CCBG Finance
- Exchange
- DNTH Nasdaq
- CCBG Nasdaq
- Market Cap
- DNTH 780.2M
- CCBG 733.2M
- IPO Year
- DNTH N/A
- CCBG N/A
- Fundamental
- Price
- DNTH $26.50
- CCBG $43.48
- Analyst Decision
- DNTH Strong Buy
- CCBG Buy
- Analyst Count
- DNTH 8
- CCBG 1
- Target Price
- DNTH $54.00
- CCBG $45.00
- AVG Volume (30 Days)
- DNTH 374.5K
- CCBG 35.0K
- Earning Date
- DNTH 11-06-2025
- CCBG 10-21-2025
- Dividend Yield
- DNTH N/A
- CCBG 2.21%
- EPS Growth
- DNTH N/A
- CCBG 14.00
- EPS
- DNTH N/A
- CCBG 3.42
- Revenue
- DNTH $4,854,000.00
- CCBG $240,944,000.00
- Revenue This Year
- DNTH N/A
- CCBG $11.91
- Revenue Next Year
- DNTH N/A
- CCBG $3.57
- P/E Ratio
- DNTH N/A
- CCBG $12.71
- Revenue Growth
- DNTH 17.87
- CCBG 8.96
- 52 Week Low
- DNTH $13.37
- CCBG $32.38
- 52 Week High
- DNTH $32.27
- CCBG $44.69
- Technical
- Relative Strength Index (RSI)
- DNTH 70.68
- CCBG 61.24
- Support Level
- DNTH $22.81
- CCBG $42.96
- Resistance Level
- DNTH $24.81
- CCBG $44.04
- Average True Range (ATR)
- DNTH 1.57
- CCBG 0.86
- MACD
- DNTH 0.22
- CCBG 0.15
- Stochastic Oscillator
- DNTH 91.57
- CCBG 75.36
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About CCBG Capital City Bank Group
Capital City Bank Group Inc is a United States-based group engaged in Banking services, Trust and asset management services, and Brokerage services. The company operates in one segment with two principal services: Banking Services and Wealth Management Services. It offers retail and commercial banking business in the form of traditional deposit and credit services, asset management, trust, mortgage banking, merchant services, bank cards, data processing, and securities brokerage services among others through its banking offices in Florida, Georgia, and Alabama.